news
Clinics Sell Three-Parent IVF for Egg Aging Without Proof
An investigation reveals offshore fertility clinics are charging over $25,000 for mitochondrial replacement therapy, pitching it to women in their forties to reverse egg decline. Scientists warn the technique, originally cleared in the UK strictly for rare inherited diseases, lacks clinical trial evidence for general fertility. Families face heavy physical strain and five-figure bills for an unproven cellular swap.
An investigation reveals offshore fertility clinics are charging over $25,000 for mitochondrial replacement therapy, pitching it to women in their forties to reverse egg decline. Scientists warn the technique, originally cleared in the UK strictly for rare inherited diseases, lacks clinical trial evidence for general fertility. Families face heavy physical strain and five-figure bills for an unproven cellular swap.
The architecture take
I used to think the wild west of reproductive longevity was just red light therapy and handfuls of CoQ10. It turns out clinics in Greece and Ukraine are swapping donor mitochondria into older eggs and charging $30,000 for the privilege. The sales pitch sounds tidy to anyone desperate to beat the clock. Mitochondria produce cellular energy, egg quality drops with age, so fresh cellular batteries ought to rescue the cycle. The biology refuses to cooperate. Older eggs struggle primarily because of chromosomal errors during division, not sluggish energy output alone. Swapping mitochondrial DNA does nothing to fix spindle defects or abnormal karyotypes. I spent an afternoon reading the pilot follow-ups, and the live birth rates look virtually identical to standard donor eggs. Desperate women are paying a massive physical premium for an unproven cellular intervention. I expect cross-border fertility scrutiny to explode by mid-2027.